Revolutionary Skin Science Meets Elegance

Summary of the Interview with Dr. Anthony Nakhla

Innovation in Clinical-Grade Skincare:
Dr. Anthony Nakhla, known for his expertise in skin cancer treatment, has developed a new line of skincare called Eighth Day. This range stands out due to its unique Peptide-rich Plasma formulation, combining bio-identical peptides, growth factors, and amino acids to enhance skin rejuvenation.

Bridging Science and Luxury:
Dr. Nakhla identified a gap in the skincare market, where luxury products often lacked potent active ingredients and clinical-grade products missed the luxury experience. Eighth Day aims to offer both efficacy and an enjoyable user experience.

Hero Ingredient Development:
The inspiration for Eighth Day’s hero ingredient came from Dr. Nakhla’s work with skin cancer patients. He used bio-identical dressings to heal wounds, exploring how such ingredients could promote anti-ageing by stimulating skin regeneration.

Superior Efficacy:
Unlike conventional products that may utilize plant or marine ingredients, Eighth Day’s formulas use molecularly identical components of human skin, enhancing the skin’s ability to repair and renew itself.

Sunscreen as Essential Skincare:
Dr. Nakhla emphasizes the importance of daily sunscreen use as it’s vital for preventing UV damage and ageing. He educates clients on proper sunscreen application to protect skin health effectively.

Future Trends in Skincare:
Dr. Nakhla sees the future of anti-ageing skincare in regenerative medicine and bio-identical technology. There’s a shift towards treatments that work at the cellular level to slow down ageing processes fundamentally.

Coverage & Recommendations:

• The article suggests related readings for those interested in skin health and includes insights from other industry experts.
• It emphasizes ongoing education on skincare practices and innovative product development.